Detection of bcl-2/JH Rearrangement in Lymphoma
Author Information
Author(s): R. Yuan, P. Dowling, E. Zuccal, H. Diggelmann, F. Cavalli
Primary Institution: Ospedale San Giovanni, Bellinzona, Switzerland
Hypothesis
Can PCR detect t(14;18) breakpoints in non-Hodgkin's lymphoma patients' blood and bone marrow?
Conclusion
PCR analysis can detect t(14;18) breakpoints in a significant number of lymphoma patients, even when bone marrow histology appears negative.
Supporting Evidence
- 86% of follicular lymphoma patients with positive bone marrow had detectable t(14;18) breakpoints.
- 58% of patients with negative bone marrow were PCR-positive for t(14;18).
- Concordance between peripheral blood and bone marrow PCR results was high, with 55 out of 56 patients showing the same results.
Takeaway
Doctors can find cancer markers in the blood and bone marrow of lymphoma patients, which helps in understanding the disease better.
Methodology
DNA samples from patients were analyzed using PCR to detect t(14;18) breakpoints.
Limitations
The study's findings may not apply after treatment, as results can diverge between blood and bone marrow.
Participant Demographics
Patients included 33 with follicular lymphoma and 38 with intermediate-grade NHL.
Want to read the original?
Access the complete publication on the publisher's website